RSS

Cobra Biologics

Innovate UK has awarded £1.5 million to a contract development and manufacturing organisation (CDMO) focused on advanced therapy medicinal products (ATMPs). Read more

News

Here, Tony Hitchcock, technical director at Cobra Biologics and Joanne Anderson, business development director at Symbiosis, discuss the challenges associated with manufacturing for gene therapies. Read more

, Opinion

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

International CDMO of biologics and pharmaceuticals, Cobra Biologics, and CMO specialising in sterile fill finish, Symbiosis Pharmaceutical Services, have been awarded a collaborative grant of £1.9 million from Innovate UK. Read more

News

Cobra Biologics has appointed Dr. Daniel Smith as its chief scientific officer with the responsibility for developing the highest level of scientific excellence across the Group and enhancing Cobra’s DNA, virus, microbial and mammalian proteins... Read more

Technology

Cobra Biologics and BioCancell have announced an agreement to manufacture BioCancell’s BC-821 cancer drug for clinical trials. Read more

Technology

Biologics and pharmaceuticals CMO Cobra Biologics has announced that its GMP Compliance Certification has been extended to include quality control (QC) testing and release of customers’ registered products for in-market supply. Read more

Technology

Cobra Biologics is a leading, international CMO providing a comprehensive biologics and pharmaceuticals service offering. With multi-functional and experienced project teams, the company nurtures its customers’ products from pre-clinical through... Read more

Technology

The loss of drug product during the filtration and fill process presents a major challenge to pharmaceutical and biologics manufacturers worldwide. For Cobra Biologics, a leading CMO providing aseptic manufacture for clinical and commercial... Read more

Technology